CMF-01138 | ZNF292 | down-regulates | RUNX3 | activates | R-192 | 11 | 3 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-01992 | PCDH9 | down-regulates | RUNX3 | activates | R-192 | 11 | 5 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-09972 | FBN1 | down-regulates | RUNX3 | activates | R-192 | 11 | 1 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-11148 | MYO18A | down-regulates | RUNX3 | activates | R-192 | 11 | 2 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-13859 | ADAMTS8 | down-regulates | RUNX3 | activates | R-192 | 11 | 2 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-16760 | CPNE8 | up-regulates | RUNX3 | activates | R-192 | 11 | 2 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-18054 | PRPF40B | down-regulates | RUNX3 | activates | R-192 | 11 | 6 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-19549 | NF1 | up-regulates | RUNX3 | activates | R-192 | 11 | 10 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-22176 | PDGFRA | down-regulates | RUNX3 | activates | R-192 | 11 | 2 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-30666 | SALL4 | down-regulates | RUNX3 | activates | R-192 | 11 | 3 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-33891 | SKAP2 | down-regulates | hsa-mir-641 | represses | R-192 | 8 | 6 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-33918 | SDPR | down-regulates | hsa-mir-30b | represses | R-192 | 9 | 3 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-34856 | NEB | down-regulates | hsa-mir-30d | represses | R-192 | 29 | 5 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-34861 | NEB | down-regulates | hsa-mir-301 | represses | R-192 | 37 | 7 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-35047 | FGFR3 | down-regulates | hsa-mir-454-3p | represses | R-192 | 31 | 29 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-35078 | FGFR3 | down-regulates | hsa-mir-20b | represses | R-192 | 44 | 26 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-35188 | SCNN1G | up-regulates | hsa-mir-106b | represses | R-192 | 21 | 13 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-35956 | AHNAK2 | up-regulates | hsa-mir-361 | represses | R-192 | 14 | 6 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-35969 | AHNAK2 | up-regulates | hsa-mir-106b | represses | R-192 | 21 | 16 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-35991 | AHNAK2 | up-regulates | hsa-mir-93 | represses | R-192 | 44 | 26 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-36019 | AHNAK2 | up-regulates | hsa-mir-20b | represses | R-192 | 44 | 26 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-36143 | TNK2 | up-regulates | hsa-mir-17-3p | represses | R-192 | 52 | 40 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-36374 | DIAPH2 | up-regulates | hsa-mir-30b | represses | R-192 | 9 | 2 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-36685 | ATP8A2 | up-regulates | hsa-mir-454-3p | represses | R-192 | 31 | 27 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-36719 | ATP8A2 | up-regulates | hsa-mir-17-3p | represses | R-192 | 52 | 40 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-36754 | ATP8A2 | up-regulates | hsa-mir-93 | represses | R-192 | 44 | 32 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-36788 | ATP8A2 | up-regulates | hsa-mir-20b | represses | R-192 | 44 | 31 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-37165 | CYP4F22 | down-regulates | hsa-mir-7 | represses | R-192 | 18 | 17 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-37181 | CYP4F22 | down-regulates | hsa-mir-30d | represses | R-192 | 29 | 18 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-37686 | ADAMTS8 | up-regulates | hsa-mir-17-3p | represses | R-192 | 52 | 40 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-37869 | PRKCD | up-regulates | hsa-mir-641 | represses | R-192 | 8 | 6 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-37953 | COL6A2 | down-regulates | hsa-mir-17-3p | represses | R-192 | 52 | 17 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-38082 | OR51F1 | up-regulates | hsa-mir-106b | represses | R-192 | 21 | 17 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-38101 | OR51F1 | up-regulates | hsa-mir-93 | represses | R-192 | 44 | 35 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-38317 | ZNF845 | up-regulates | hsa-mir-454-3p | represses | R-192 | 31 | 27 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-38344 | ZNF845 | up-regulates | hsa-mir-641 | represses | R-192 | 8 | 5 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-38404 | KCNB2 | down-regulates | hsa-mir-30d | represses | R-192 | 29 | 5 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-38409 | KCNB2 | down-regulates | hsa-mir-361 | represses | R-192 | 14 | 4 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-38413 | KCNB2 | down-regulates | hsa-mir-301 | represses | R-192 | 37 | 5 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-38421 | KCNB2 | down-regulates | hsa-mir-106b | represses | R-192 | 21 | 15 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-38440 | KCNB2 | down-regulates | hsa-mir-17-3p | represses | R-192 | 52 | 36 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-38473 | KCNB2 | down-regulates | hsa-mir-93 | represses | R-192 | 44 | 27 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-38563 | CPNE8 | down-regulates | hsa-mir-17-3p | represses | R-192 | 52 | 28 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-38587 | CPNE8 | down-regulates | hsa-mir-93 | represses | R-192 | 44 | 20 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-39131 | DNMBP | down-regulates | hsa-mir-17-3p | represses | R-192 | 52 | 35 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-39222 | ZNF569 | up-regulates | hsa-mir-7 | represses | R-192 | 18 | 3 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-39331 | INPP5J | up-regulates | hsa-mir-641 | represses | R-192 | 8 | 5 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-39554 | NF1 | down-regulates | hsa-mir-106b | represses | R-192 | 21 | 20 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-39622 | NF1 | down-regulates | hsa-mir-93 | represses | R-192 | 44 | 31 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-39712 | NF1 | down-regulates | hsa-mir-20b | represses | R-192 | 44 | 31 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-39741 | RPSAP58 | down-regulates | hsa-mir-301 | represses | R-192 | 37 | 12 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-39761 | RPSAP58 | down-regulates | hsa-mir-17-3p | represses | R-192 | 52 | 40 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-39792 | RPSAP58 | down-regulates | hsa-mir-641 | represses | R-192 | 8 | 7 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-39818 | UGT2B4 | down-regulates | hsa-mir-149 | represses | R-192 | 51 | 35 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-39898 | TDRD9 | down-regulates | hsa-mir-30d | represses | R-192 | 29 | 16 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-39913 | TDRD9 | down-regulates | hsa-mir-361 | represses | R-192 | 14 | 9 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-39925 | TDRD9 | down-regulates | hsa-mir-106b | represses | R-192 | 21 | 21 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-39953 | TDRD9 | down-regulates | hsa-mir-17-3p | represses | R-192 | 52 | 42 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-40133 | STAB2 | up-regulates | hsa-mir-106b | represses | R-192 | 21 | 8 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-40306 | MUC17 | down-regulates | hsa-mir-30b | represses | R-192 | 9 | 9 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-41265 | TP53 | up-regulates | hsa-mir-301 | represses | R-192 | 37 | 28 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-41325 | TP53 | up-regulates | hsa-mir-17-3p | represses | R-192 | 52 | 52 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-41373 | TP53 | up-regulates | hsa-mir-93 | represses | R-192 | 44 | 44 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-41534 | TP53 | up-regulates | hsa-mir-20b | represses | R-192 | 44 | 44 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-42182 | NAALADL1 | down-regulates | hsa-mir-301 | represses | R-192 | 37 | 10 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-42349 | SDK1 | down-regulates | hsa-mir-7 | represses | R-192 | 18 | 14 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-42386 | KRTAP20-2 | down-regulates | hsa-mir-7 | represses | R-192 | 18 | 15 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-42417 | ANKRD36 | down-regulates | hsa-mir-30d | represses | R-192 | 29 | 11 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-42437 | ANKRD36 | down-regulates | hsa-mir-641 | represses | R-192 | 8 | 6 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-42785 | AQP10 | up-regulates | hsa-mir-301 | represses | R-192 | 37 | 10 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-43248 | PROKR2 | up-regulates | hsa-mir-30b | represses | R-192 | 9 | 4 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-43284 | POLRMT | down-regulates | hsa-mir-7 | represses | R-192 | 18 | 7 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-43292 | POLRMT | down-regulates | hsa-mir-17-3p | represses | R-192 | 52 | 9 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-43336 | LRFN2 | up-regulates | hsa-mir-30b | represses | R-192 | 9 | 4 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |